IRIS
ZAPPAVIGNA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.528
NA - Nord America 3.086
AS - Asia 2.531
SA - Sud America 350
AF - Africa 46
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.554
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.922
US - Stati Uniti d'America 3.054
SG - Singapore 910
IE - Irlanda 800
IT - Italia 618
CN - Cina 611
HK - Hong Kong 345
BR - Brasile 307
GB - Regno Unito 245
DE - Germania 231
UA - Ucraina 227
KR - Corea 184
VN - Vietnam 168
FR - Francia 131
SE - Svezia 91
FI - Finlandia 85
IN - India 76
GR - Grecia 72
JP - Giappone 68
TR - Turchia 53
AR - Argentina 21
BE - Belgio 21
PK - Pakistan 20
PL - Polonia 20
AT - Austria 18
CA - Canada 17
ZA - Sudafrica 17
ID - Indonesia 15
NL - Olanda 15
BD - Bangladesh 14
MA - Marocco 11
MX - Messico 10
UZ - Uzbekistan 10
IR - Iran 9
EC - Ecuador 8
ES - Italia 8
IQ - Iraq 8
AU - Australia 7
CO - Colombia 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
PH - Filippine 6
EU - Europa 4
KE - Kenya 4
SN - Senegal 4
TW - Taiwan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
KZ - Kazakistan 3
NP - Nepal 3
AL - Albania 2
AM - Armenia 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
TN - Tunisia 2
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PW - Palau 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 13.554
Salva come PNG Salva come JPEG
Città #
Moscow 1.693
Dublin 800
Chandler 517
Santa Clara 439
Singapore 402
Jacksonville 363
Hong Kong 344
Dallas 182
Seoul 175
Hefei 117
Caserta 98
Princeton 96
Naples 90
New York 89
Roxbury 83
Beijing 82
Ashburn 81
Medford 73
Bengaluru 62
Boardman 58
Bremen 58
Ann Arbor 54
Dong Ket 54
Ho Chi Minh City 45
Los Angeles 43
The Dalles 43
Munich 39
Des Moines 35
Cambridge 33
Wilmington 33
Napoli 31
Aversa 30
São Paulo 26
Nuremberg 25
Woodbridge 25
Helsinki 24
Mountain View 24
San Mateo 22
Brussels 20
Hanoi 20
Milan 20
Rome 13
Campodarsego 11
Rio de Janeiro 11
Guangzhou 10
Istanbul 10
Johannesburg 10
San Nicola la Strada 10
Warsaw 10
Falkenstein 9
Frankfurt am Main 9
Jinan 9
San Felice A Cancello 9
Tashkent 9
Boston 8
Haiphong 8
Changsha 7
Elora 7
Houston 7
Jakarta 7
Nanjing 7
Piscataway 7
Redwood City 7
Tianjin 7
Vienna 7
Xi'an 7
Amsterdam 6
Columbus 6
Curitiba 6
Düsseldorf 6
London 6
Ningbo 6
Norwalk 6
Seregno 6
Auburn Hills 5
Belo Horizonte 5
Brno 5
Cagliari 5
Clifton 5
Kunming 5
Lappeenranta 5
Lissone 5
Madrid 5
Porto Alegre 5
San Francisco 5
Santo André 5
Scafati 5
Stockholm 5
Tokyo 5
Bahawalpur 4
Berlin 4
Brasília 4
Campinas 4
Cape Town 4
Chengdu 4
Chicago 4
Dakar 4
Delhi 4
Guarulhos 4
Montreal 4
Totale 6.931
Salva come PNG Salva come JPEG
Nome #
Mitochondria as playmakers of apoptosis, autophagy and senescence 181
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 179
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 174
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 173
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 171
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 170
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 169
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 167
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 164
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 163
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 162
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 162
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 161
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 161
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 159
Anti-inflammatory drugs as anticancer agents 158
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 157
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 157
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 154
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 151
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 151
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 145
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 145
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 144
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 144
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 143
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 141
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 139
Immune cell infiltration and inflammatory landscape in primary brain tumours 138
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 136
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 136
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 136
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 130
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 129
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 128
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 127
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 127
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 127
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 127
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 126
Emerging pathways as individualized therapeutic target of multiple myeloma. 125
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 125
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 124
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 123
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 122
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 122
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 122
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 121
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 120
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 120
The role of micrornas in development of colitis-associated colorectal cancer 119
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 117
Autophagic cell death: A new frontier in cancer research 116
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 115
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 114
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 114
Poly(ε-caprolactone)-poly(ethylene glycol) Tri-Block Copolymer as Quercetin Delivery System for Human Colorectal Carcinoma Cells: Synthesis, Characterization and In Vitro Study 114
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 113
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 113
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 113
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide 112
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 112
Characterization of KRAS Mutational Regression in Oligometastatic Patients 112
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 112
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 110
Evolutionary conservation of a regulative pathway of erythropoiesis in Poikilothermic vertebrates 110
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 110
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 110
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 109
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 108
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 108
Interleukin 18: Friend or foe in cancer. 106
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 106
Long non-coding RNAs in cancer stem cells 106
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 106
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 105
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 104
Measurement of autophagy by flow cytometry 104
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 104
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 104
Erlotinib: early clinical development in brain cancer. 102
Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer 101
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 100
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 100
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use 98
Hepatocarcinoma: genetic and epigenetic features 97
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 97
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 95
Testicular cancer from diagnosis to epigenetic factors 94
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 93
Ipilimumab for the treatment of metastatic prostate cancer 93
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 93
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 92
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 91
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 91
Non-coding RNAs as a new dawn in tumor diagnosis 88
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications 87
Protein kinase a detection in human urine samples 87
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 86
Peptide functionalization of silicon for detection and classification of prostatic cells 82
Totale 12.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.566
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021432 0 0 0 0 0 27 84 50 51 67 83 70
2021/2022688 24 11 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024740 72 32 54 37 202 93 19 20 12 5 51 143
2024/20251.914 17 46 8 99 287 301 233 178 285 185 158 117
2025/20266.988 341 441 550 337 694 4.625 0 0 0 0 0 0
Totale 13.933